Wealthcare Capital Partners’s Vanguard FTSE Developed Markets ETF VEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.11M Sell
29,625
-401
-1% -$27.9K 0.87% 21
2026
Q1
$1.92M Sell
30,026
-402
-1% -$26.5K 0.9% 21
2025
Q4
$1.9M Sell
30,428
-84
-0.3% -$5.15K 0.89% 23
2025
Q3
$1.83M Buy
30,512
+4,000
+15% +$233K 0.84% 24
2025
Q2
$1.51M Buy
26,512
+1,297
+5% +$69.5K 0.76% 26
2025
Q1
$1.28M Buy
25,215
+1,673
+7% +$84.7K 0.66% 27
2024
Q4
$1.13M Buy
+23,542
New +$1.18M 0.59% 30

Other funds holding VEA

Wealthcare Capital Partners's VEA Position: Q2 2026 in Review

Wealthcare Capital Partners reduced its Vanguard FTSE Developed Markets ETF (VEA) stake by 1.3% in Q2 2026, selling an estimated $27.9K and leaving 29,625 shares worth $2.11M. The position accounts for 0.87% of the portfolio, ranked #21.

Wealthcare Capital Partners first reported a position in VEA in Q4 2024 and has held it in 7 quarters since. 1,585 funds tracked by Wall St. Rank hold VEA as of Q2 2026.

  • Wealthcare Capital Partners held 29,625 shares of Vanguard FTSE Developed Markets ETF worth $2.11M as of Q2 2026.
  • Wealthcare Capital Partners sold 401 Vanguard FTSE Developed Markets ETF shares in Q2 2026, an estimated $27.9K.
  • Vanguard FTSE Developed Markets ETF made up 0.87% of Wealthcare Capital Partners's portfolio in Q2 2026, its #21 holding.
  • Wealthcare Capital Partners first reported a position in Vanguard FTSE Developed Markets ETF in Q4 2024 and has held it in 7 quarters since.
  • 1,585 funds tracked by Wall St. Rank held Vanguard FTSE Developed Markets ETF as of Q2 2026.

Based on Wealthcare Capital Partners's 13F filing for Q2 2026, filed 9 Jul 2026.